Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Derks

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Scientific Reports|October 12, 2019
Transcriptome analysis suggests a compensatory role of the cofactors coenzyme A and NAD<sup>+</sup> in medium-chain acyl-CoA dehydrogenase knockout miceAnne-Claire M F Martines, Albert Gerding, Sarah Stolle, et al.
Hepatology (Baltimore, Md.)|June 22, 2021
Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR-associated protein 9-Mediated Gene EditingMartijn G S Rutten, Terry G J Derks, Nicolette C A Huijkman, et al.
JHEP Reports : Innovation in Hepatology|July 11, 2022
High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type IaMartijn P D Haring, Fabian Peeks, Maaike H Oosterveer, et al.
Journal of Inherited Metabolic Disease|February 5, 2021
Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiencyWillemijn J van Rijt, Johan L K Van Hove, Frédéric M Vaz, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 27, 2025
Person-centered outcomes for liver glycogen storage diseases: Development of an international consensus-based standard outcome setRuben J Overduin, Andrea B Haijer-Schreuder, Frederiec K Withaar, et al.
Journal of Inherited Metabolic Disease|February 12, 2019
Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiencyJeannette C Bleeker, Irene L Kok, Sacha Ferdinandusse, et al.
Journal of Inherited Metabolic Disease|March 1, 2019
Movement disorders and nonmotor neuropsychological symptoms in children and adults with classical galactosemiaAnouk Kuiper, Stephanie Grünewald, Elaine Murphy, et al.
Journal of Inherited Metabolic Disease|January 15, 2021
Effects of acute nutritional ketosis during exercise in adults with glycogen storage disease type IIIa are phenotype-specific: An investigator-initiated, randomized, crossover studyIrene J Hoogeveen, Foekje de Boer, Willemijn F Boonstra, et al.
BMC Biology|December 9, 2016
Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disordersKaren van Eunen, Catharina M L Volker-Touw, Albert Gerding, et al.
Journal of Inherited Metabolic Disease|February 18, 2020
Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendationsAlessandro Rossi, Irene J Hoogeveen, Vanessa B Bastek, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Scientific Reports|October 12, 2019
Transcriptome analysis suggests a compensatory role of the cofactors coenzyme A and NAD<sup>+</sup> in medium-chain acyl-CoA dehydrogenase knockout miceAnne-Claire M F Martines, Albert Gerding, Sarah Stolle, et al.
Hepatology (Baltimore, Md.)|June 22, 2021
Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR-associated protein 9-Mediated Gene EditingMartijn G S Rutten, Terry G J Derks, Nicolette C A Huijkman, et al.
JHEP Reports : Innovation in Hepatology|July 11, 2022
High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type IaMartijn P D Haring, Fabian Peeks, Maaike H Oosterveer, et al.
Journal of Inherited Metabolic Disease|February 5, 2021
Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiencyWillemijn J van Rijt, Johan L K Van Hove, Frédéric M Vaz, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 27, 2025
Person-centered outcomes for liver glycogen storage diseases: Development of an international consensus-based standard outcome setRuben J Overduin, Andrea B Haijer-Schreuder, Frederiec K Withaar, et al.
Journal of Inherited Metabolic Disease|February 12, 2019
Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiencyJeannette C Bleeker, Irene L Kok, Sacha Ferdinandusse, et al.
Journal of Inherited Metabolic Disease|March 1, 2019
Movement disorders and nonmotor neuropsychological symptoms in children and adults with classical galactosemiaAnouk Kuiper, Stephanie Grünewald, Elaine Murphy, et al.
Journal of Inherited Metabolic Disease|January 15, 2021
Effects of acute nutritional ketosis during exercise in adults with glycogen storage disease type IIIa are phenotype-specific: An investigator-initiated, randomized, crossover studyIrene J Hoogeveen, Foekje de Boer, Willemijn F Boonstra, et al.
BMC Biology|December 9, 2016
Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disordersKaren van Eunen, Catharina M L Volker-Touw, Albert Gerding, et al.
Journal of Inherited Metabolic Disease|February 18, 2020
Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendationsAlessandro Rossi, Irene J Hoogeveen, Vanessa B Bastek, et al.
Pageof 17